Welcome to our dedicated page for West Pharm Svcs news (Ticker: WST), a resource for investors and traders seeking the latest updates and insights on West Pharm Svcs stock.
West Pharmaceutical Services (WST) delivers essential innovations in pharmaceutical packaging and injectable drug delivery systems. This page provides investors and industry professionals with timely updates on the company’s strategic developments, financial performance, and technological advancements.
Access authoritative reporting on WST’s earnings announcements, regulatory milestones, product launches, and global partnerships. Our curated news ensures you stay informed about critical developments in elastomer-based components, biologics containment, and self-injection device platforms.
Explore updates across key areas: quarterly financial results, manufacturing expansions, compliance achievements, and collaborations with healthcare leaders. Content is rigorously verified to support data-driven decisions while adhering to financial disclosure standards.
Bookmark this page for streamlined access to WST’s evolving role in advancing safe, efficient drug delivery solutions worldwide. Check regularly for unbiased insights into one of pharma packaging’s most innovative players.
West Pharmaceutical Services (NYSE: WST) will release its second-quarter 2024 financial results on July 25, 2024, before the market opens. A conference call is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the results and business outlook. Interested participants must register in advance to receive the dial-in number and unique PIN for the call. The call will be accompanied by a slide presentation available on the company's website. A live audio webcast and subsequent replay will also be accessible in the 'Investors' section of the website, with the replay available for 30 days post-event.
West Pharmaceutical Services (NYSE: WST) has introduced Daikyo Crystal Zenith® (CZ) Nested Vials at the International Society for Cell and Gene Therapy Annual Meeting in Vancouver, Canada from May 29-June 1, 2024.
Designed to meet ISO 8362-1 standards, the vials are compatible with a range of aseptic fill-finish equipment. They offer features such as break resistance, low particulate specification, and low risk of chemical interaction.
Available in 2mL and 10mL sizes, the vials come with flexible closure options and are suitable for storing gene therapy drugs from preclinical to commercial phases. Chief Commercial Officer Cindy Reiss-Clark stated that this product expands CZ's platform for flexible filling solutions of sensitive molecules.
West Pharmaceutical Services (NYSE: WST) announced its participation in the William Blair 44th Annual Growth Stock Conference in Chicago, IL, on June 4, 2024, at 8:00 AM CT. The event will feature a live audio webcast available on the company's website, www.westpharma.com, in the 'Investors' section. The webcast replay will be accessible for 90 days post-event.
West Pharmaceutical Services, Inc. (NYSE: WST) will participate in the Bank of America Securities Healthcare Conference in Las Vegas, NV on May 14, 2024. The company will present at 11:20 AM PT and offer a live audio webcast on their website. Investors can access the webcast on www.westpharma.com.
FAQ
What is the current stock price of West Pharm Svcs (WST)?
What is the market cap of West Pharm Svcs (WST)?
